These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 9397099)

  • 41. Prevention of Group B Streptococcus early-onset disease: a toolkit by the California Perinatal Quality Care Collaborative.
    Powers RJ; Wirtschafter D;
    J Perinatol; 2010 Feb; 30(2):77-87. PubMed ID: 19657350
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevention of perinatal group B streptococcal disease: a public health perspective. Centers for Disease Control and Prevention.
    MMWR Recomm Rep; 1996 May; 45(RR-7):1-24. PubMed ID: 8637497
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Risk factors for early onset neonatal group B streptococcal sepsis: case-control study.
    Oddie S; Embleton ND
    BMJ; 2002 Aug; 325(7359):308. PubMed ID: 12169506
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Strategies for the prevention of early-onset neonatal group B streptococcal sepsis: a decision analysis.
    Rouse DJ; Goldenberg RL; Cliver SP; Cutter GR; Mennemeyer ST; Fargason CA
    Obstet Gynecol; 1994 Apr; 83(4):483-94. PubMed ID: 8134056
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Group B Streptococcus and preterm premature rupture of membranes: a randomized, double-blind clinical trial of antepartum ampicillin.
    Grable IA; Garcia PM; Perry D; Socol ML
    Am J Obstet Gynecol; 1996 Oct; 175(4 Pt 1):1036-42. PubMed ID: 8885772
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adoption of hospital policies for prevention of perinatal group B streptococcal disease--United States, 1997.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1998 Aug; 47(32):665-70. PubMed ID: 9729032
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Early-onset group B streptococcal disease in the era of maternal screening.
    Puopolo KM; Madoff LC; Eichenwald EC
    Pediatrics; 2005 May; 115(5):1240-6. PubMed ID: 15867030
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of prevention strategies for neonatal group B streptococcal infection. A population-based economic analysis.
    Mohle-Boetani JC; Schuchat A; Plikaytis BD; Smith JD; Broome CV
    JAMA; 1993 Sep 22-29; 270(12):1442-8. PubMed ID: 8371444
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of universal maternal screening on the incidence of neonatal early-onset group B streptococcal disease.
    Eberly MD; Rajnik M
    Clin Pediatr (Phila); 2009 May; 48(4):369-75. PubMed ID: 18832528
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevention of group B Streptococcus infection in neonates.
    Logsdon BA; Casto DT
    Ann Pharmacother; 1997; 31(7-8):897-906. PubMed ID: 9220054
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevention of group B streptococcal infection in newborns. Recommendation statement from the Canadian Task Force on Preventive Health Care.
    Canadian Task Force on Preventive Health Care
    Can Fam Physician; 2002 May; 48():934-5, 944-6. PubMed ID: 12053638
    [No Abstract]   [Full Text] [Related]  

  • 52. [Prevention of neonatal group B streptococcal sepsis in Hungary in 2012. Preliminary data of a nation-wide survey].
    Sziller I; Szabó M; Valek A; Rigó B; Ács N
    Orv Hetil; 2014 Jul; 155(29):1167-72. PubMed ID: 25016449
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy of a strategy to prevent neonatal early-onset group B streptococcal (GBS) sepsis.
    Renner RM; Renner A; Schmid S; Hoesli I; Nars P; Holzgreve W; Surbek DV
    J Perinat Med; 2006; 34(1):32-8. PubMed ID: 16489884
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prenatal screening for group B Streptococcus. II. Impact of antepartum screening and prophylaxis on neonatal care.
    Mercer BM; Ramsey RD; Sibai BM
    Am J Obstet Gynecol; 1995 Sep; 173(3 Pt 1):842-6. PubMed ID: 7573255
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Universal screening vs. risk-based strategy for prevention of early-onset neonatal Group-B streptococcal disease.
    Abdelmaaboud M; Mohammed AF
    J Trop Pediatr; 2011 Dec; 57(6):444-50. PubMed ID: 21335324
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevention of early onset group B streptococcal disease: controversial issues.
    Tzialla C; Borghesi A; Garofoli F; Bollani L; Longo S; Stronati M
    J Matern Fetal Neonatal Med; 2009; 22 Suppl 3():38-42. PubMed ID: 19718586
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Group B streptococcus intrapartum prophylaxis guidelines adherence: a perinatal risk management issue.
    Hanson L; Vandevusse L
    J Perinat Neonatal Nurs; 2010; 24(2):100-3. PubMed ID: 20442605
    [No Abstract]   [Full Text] [Related]  

  • 58. Cervical insufficiency: a new issue for guidelines on prevention of perinatal group B streptococcal disease?
    Natale F; Brunelli R; Bizzarri B; Castronovo A; De Curtis M
    Pediatrics; 2013 Feb; 131(2):e612-5. PubMed ID: 23296432
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Policy statement—Recommendations for the prevention of perinatal group B streptococcal (GBS) disease.
    ; ; Baker CJ; Byington CL; Polin RA
    Pediatrics; 2011 Sep; 128(3):611-6. PubMed ID: 21807694
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effectiveness of risk-based intrapartum chemoprophylaxis for the prevention of early-onset neonatal group B streptococcal disease.
    Lin FY; Brenner RA; Johnson YR; Azimi PH; Philips JB; Regan JA; Clark P; Weisman LE; Rhoads GG; Kong F; Clemens JD
    Am J Obstet Gynecol; 2001 May; 184(6):1204-10. PubMed ID: 11349189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.